MOH — authorised 27 May 2015
- Marketing authorisation holder: FURIEX PHARMA INC
- Status: likely_approved
MOH authorised Viberzi on 27 May 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 27 May 2015.
FURIEX PHARMA INC holds the Israeli marketing authorisation.